Oncimmune Company
Biomarker proprietary platform to test for cancer cell signatures, during/post therapy.
Technology:
AgeTech Companies
Industry:
Healthcare (Diagnostic Tool)
Headquarters:
United Kingdom
Founded Date:
2006-01-01
Funding Status:
M&A
Total Funding:
$6 818 006
Estimated Revenue:
Less than $1M
Last Funding Date:
2017-09-27
Last Funding Type:
Post-IPO Equity
Register and Claim Ownership